353 related articles for article (PubMed ID: 21689280)
1. The first 3 years of national bowel cancer screening at a single UK tertiary centre.
Gupta S; Saunders BP; Fraser C; Kennedy RH; Ignjatovic A; Sala S; Marshall S; Suzuki N; Vance M; Thomas-Gibson S
Colorectal Dis; 2012 Feb; 14(2):166-73. PubMed ID: 21689280
[TBL] [Abstract][Full Text] [Related]
2. Flexible sigmoidoscopy following a positive faecal occult blood test within a bowel screening programme may reduce the detection of neoplasia.
Mansouri D; McMillan DC; Roxburgh CS; Moug SJ; Crighton EM; Horgan PG
Colorectal Dis; 2013 Nov; 15(11):1375-81. PubMed ID: 23927751
[TBL] [Abstract][Full Text] [Related]
3. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme.
Lee TJ; Rutter MD; Blanks RG; Moss SM; Goddard AF; Chilton A; Nickerson C; McNally RJ; Patnick J; Rees CJ
Gut; 2012 Jul; 61(7):1050-7. PubMed ID: 21940723
[TBL] [Abstract][Full Text] [Related]
4. Screening for colorectal cancer in Italy: 2005 survey.
Zorzi M; Barca A; Falcini F; Grazzini G; Pizzuti R; Ravaioli A; Sassoli de Bianchi P; Senore C; Sigillito A; Vettorazzi M; Visioli C
Epidemiol Prev; 2007; 31(2-3 Suppl 2):49-60. PubMed ID: 17824362
[TBL] [Abstract][Full Text] [Related]
5. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.
Graser A; Stieber P; Nagel D; Schäfer C; Horst D; Becker CR; Nikolaou K; Lottes A; Geisbüsch S; Kramer H; Wagner AC; Diepolder H; Schirra J; Roth HJ; Seidel D; Göke B; Reiser MF; Kolligs FT
Gut; 2009 Feb; 58(2):241-8. PubMed ID: 18852257
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer mass screening event utilising quantitative faecal occult blood test.
Chew MH; Suzanah N; Ho KS; Lim JF; Ooi BS; Tang CL; Eu KW
Singapore Med J; 2009 Apr; 50(4):348-53. PubMed ID: 19421676
[TBL] [Abstract][Full Text] [Related]
7. Colonoscopy conversion after flexible sigmoidoscopy screening: results from the UK Bowel Scope Screening Programme.
Siau K; Yew AC; Ishaq S; Jewes S; Shetty S; Brookes M; Veitch A; McKaig B; Murugananthan A
Colorectal Dis; 2018 Jun; 20(6):502-508. PubMed ID: 29205835
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
9. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
[TBL] [Abstract][Full Text] [Related]
10. Nonneoplastic polypectomy during screening colonoscopy: the impact on polyp detection rate, adenoma detection rate, and overall cost.
Atia MA; Patel NC; Ratuapli SK; Boroff ES; Crowell MD; Gurudu SR; Faigel DO; Leighton JA; Ramirez FC
Gastrointest Endosc; 2015 Aug; 82(2):370-375.e1. PubMed ID: 25843614
[TBL] [Abstract][Full Text] [Related]
11. Colonoscopist Performance and Colorectal Cancer Risk After Adenoma Removal to Stratify Surveillance: Two Nationwide Observational Studies.
Wieszczy P; Waldmann E; Løberg M; Regula J; Rupinski M; Bugajski M; Gray K; Kalager M; Ferlitsch M; Kaminski MF; Bretthauer M
Gastroenterology; 2021 Mar; 160(4):1067-1074.e6. PubMed ID: 33065063
[TBL] [Abstract][Full Text] [Related]
12. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
[TBL] [Abstract][Full Text] [Related]
13. Long-term risk of colorectal cancer in individuals with serrated polyps.
Holme Ø; Bretthauer M; Eide TJ; Løberg EM; Grzyb K; Løberg M; Kalager M; Adami HO; Kjellevold Ø; Hoff G
Gut; 2015 Jun; 64(6):929-36. PubMed ID: 25399542
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
15. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
Lieberman DA; Weiss DG;
N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
[TBL] [Abstract][Full Text] [Related]
16. Differences in screening vs non-screening colonoscopy: scope for improvement?
Ahmed S; Naumann DN; Karandikar S
Colorectal Dis; 2016 Sep; 18(9):903-9. PubMed ID: 26850216
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer screening in asymptomaic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests.
Cheng TI; Wong JM; Hong CF; Cheng SH; Cheng TJ; Shieh MJ; Lin YM; Tso CY; Huang AT
J Formos Med Assoc; 2002 Oct; 101(10):685-90. PubMed ID: 12517041
[TBL] [Abstract][Full Text] [Related]
18. Using CT colonography as a triage technique after a positive faecal occult blood test in colorectal cancer screening.
Liedenbaum MH; van Rijn AF; de Vries AH; Dekker HM; Thomeer M; van Marrewijk CJ; Hol L; Dijkgraaf MG; Fockens P; Bossuyt PM; Dekker E; Stoker J
Gut; 2009 Sep; 58(9):1242-9. PubMed ID: 19625276
[TBL] [Abstract][Full Text] [Related]
19. High quality of screening colonoscopy in Austria is not dependent on endoscopist specialty or setting.
Kozbial K; Reinhart K; Heinze G; Zwatz C; Bannert C; Salzl P; Waldmann E; Britto-Arias M; Ferlitsch A; Trauner M; Weiss W; Ferlitsch M
Endoscopy; 2015 Mar; 47(3):207-16. PubMed ID: 25412094
[TBL] [Abstract][Full Text] [Related]
20. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.
Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
